These findings imply that the blood–retina barrier mediates the retinal vascular disruption involved in AD and that retinal vascular parameters (e.g., vascular Aβ and PDGFRβ signaling) might be early signs of the occurrence of AD. The gene discussed is PDGFRB; the disease is Alzheimer disease.